Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment

European Journal of Clinical Pharmacology

Volumn 51, Issue 5, 1997, Pages 407-414

  Gourlay, S G ^a,b   Benowitz, N L ^a   Forbes, A ^b   McNeil, J J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cotinine; Nicotine; Plasma concentrations; Smoking cessation; Transdermal

Indexed keywords

COTININE; DRUG METABOLITE; NICOTINE;

ARTICLE; DRUG BLOOD LEVEL; DRUG METABOLISM; HUMAN; INTRADERMAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SMOKING CESSATION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AUSTRALIA; COTININE; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; SMOKING;

EID: 0031014866     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050222     Document Type: Article

References (23)

1. Benowitz NL, Jacob III P, Yu L, Talcott R, Hall S, Jones RT (1986) Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow - but not low-yield cigarettes. JAMA 256: 241-246
2. Coultas DB, Stidley CA, Samet JM (1993) Cigarette yields of tar and nicotine and markers of exposure to tobacco smoke. Am Rev Resp Dis 148: 435-440
3. Nørregaard J, Tønnesen P, Peterson L (1993) Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med 22: 261-271
4. Tønnesen P, Norregaard J, Simonsen K, Säwe U (1991) A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 325: 311-15
5. Stapleton JA, Russell MAH, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U (1995) Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 90: 31-42
6. Benowitz NL, Jacob III P (1994) Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharm Ther 56: 483-493
7. Benowitz NL, Jacob III P (1984) Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther 35: 499-504
8. Hurt RD, Dale LC, Offord KP et al. (1993) Serum nicotine and cotinine levels during nicotine patch therapy. Clin Pharm Ther 54: 98-106
9. Hurt RD, Dale LC, Fredrickson PA et al. (1994) Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: one year outcome and percentage of nicotine replacement. JAMA 271: 595-600
10. Benowitz NL, Jacob III P, Olsson P, Johansson C-J (1992) Intravenous nicotine retards transdermal absorption of nicotine: evidence of blood flow-limited percutaneous absorption. Clin Pharm Ther 52: 223-230
11. Sachs DP, Benowitz NL, Bostrum AG, Hansen MD (1995) Percent serum replacement and success of nicotine patch therapy. Am J Respir Crit Care Med 151: A688
12. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ (1994) A prospective study of factors predicting smoking cessation using transdermal nicotine therapy. BMJ 309: 842-846
13. Drummer OH, Horomidis S, Kourtis S, Syrjanen ML, Tippett P (1994) Capillary gas Chromatographic drug screening for use in forensic toxicology. J Analytical Toxicol 18: 134-138
14. Jacob III P, Wilson M, Benowitz NL (1981) Improved gas Chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatog, Biomed Applications 222: 61-70
15. 2 in humans. Biol Mass Spectrometry 20: 247-252
16. Therapeutic Goods Administration (1991) Good Clinical Research Practice Guidelines. Australian Department of Community Services and Health, Canberra.
17. Gourlay SG, McNeil JJ (1990) Antismoking Products. Med J Aust 153: 699-707
18. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K-O (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Brit J Addict 86: 1119-1127
19. Gori GB, Lynch CJ (1985) Analytical cigarette yields as predictors of smoke bioavailability. Regulatory Toxicol & Pharmacol 5: 314-326
20. Russell MAH, Jarvis M, lyer R, Feyerabend C (1980) Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J 1: 972-976
21. Transdermal nicotine study group. Transdermal nicotine for smoking cessation. JAMA 266: 3133-3138
22. Jorenby DE, Smith SS, Fiore MC et al. (1995) Varying nicotine patch dose and type of smoking cessation counseline. JAMA 274: 1347-1352
23. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR (1995) High dose nicotine patch therapy: percentage of replacement and smoking cessation. JAMA 274: 1353-1358